Table: Shin Nippon Biomedical -2015/16 group results

Shin Nippon Biomedical Laboratories

13/05/2016 08:00

May 13 (Reuters)-  
          Shin Nippon Biomedical Laboratories Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended        Year to         NEXT      
              Mar 31, 2016    Mar 31, 2015    Mar 31, 2017       YEAR        
                 LATEST         YEAR-AGO         COMPANY         COMPANY     
                 RESULTS         RESULTS        FORECAST       H1 FORECAST   
  Sales           14.75           17.84           16.50           7.00       
               (-17.3 pct)     (+5.4 pct)      (+11.9 pct)     (+6.7 pct)    
  Operating     loss 3.86     loss 636 mln      loss 2.25       loss 1.84    
  Recurring     loss 5.26        155 mln        loss 2.78       loss 2.23    
  Net 
  Net              2.65         loss 1.39       loss 2.92       loss 2.27    
  EPS           66.52 yen    loss 34.83 yen  loss 73.41 yen  loss 57.04 yen  
  Ann Div          NIL             NIL                                       
  -Q2 Div          NIL             NIL                                       
  -Q4 Div          NIL             NIL                                       
   
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T 
  ((Tokyo Headline News Desk +813 6441 1812))